One biologic, adalimumab, is currently approved to treat hidradenitis suppurativa. Adalimumab works by targeting a specific inflammation pathway involved in the condition. Hidradenitis suppurativa (HS ...

Kesimpta is a prescription drug used to treat specific types of multiple sclerosis (MS) as well as clinically isolated syndrome (CIS). Common side effects of Kesimpta include back pain, upper ...

Major advancements in psoriasis treatments in the past two decades have given people living with the autoimmune condition a wide range of options for controlling symptoms. There are more than a dozen ...

Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib Sequential tumor biopsies from 33 patients were examined.

The US Food and Drug Administration (FDA) has approved more than 23,000 prescription drugs, with many more in development. Increasingly, therapeutic manufacturers are discovering that the key to ...

Risk perceptions in localized breast cancer (BC). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.